The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
There has been rapid growth in studies involving TM in diabetes treatment in recent years. In France, while TM has proven its efficacy in DT1, there have been relatively few trials in T2D. Nevertheless, certain studies in the US have already shown benefits in terms of metabolic parameters compared with especially conventional treatment, which, in view of the high number of patients in a position to...
To be effective in the treatment of type 1 diabetes (T1D), telemedicine (TM) must answer the key question of the patient: what dose of insulin to inject? The answer to this question can be provided by means of a powerful tool that the patient can carry around with him, allowing simple and frequent communication with the caregiver, a key condition for the provision of effective motivational support...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.